Cormedix Inc stock is traded at $5.25, with a volume of 759,288. It is down -0.94% in the last 24 hours and down -29.62% over the past month. Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Previous Close:
$5.30
Open:
$5.15
24h Volume:
759,288
Relative Volume:
0.29
Market Cap:
$417.26M
Revenue:
$400.05M
Net Income/Loss:
$181.01M
P/E Ratio:
2.50
EPS:
$2.10
Net Cash Flow:
$194.58M
1W Performance:
+0.38%
1M Performance:
-29.62%
6M Performance:
-30.09%
1Y Performance:
-54.03%
1-Day Range:
$5.15$5.49
1-Week Range:
$5.10$5.68
52-Week Range:
$5.10$13.02
Cormedix Inc Stock (CRMD) Company Profile
Name
Cormedix IncSector
HealthcareIndustry
BiotechnologyPhone
908-517-9500Address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS